Akèy › Sendwòm myelodisplastik › Kansas › Overland Park
Etid klinik pou Sendwòm myelodisplastik nan Overland Park, KS
3 etid pou Sendwòm myelodisplastik ap chèche patisipan nan sit nan ak bò kote Overland Park (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Ap rekriteFaz 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · 3 mi lwen
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- University of Kansas Clinical Research Center, Fairway · 3 mi lwen
Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
Ap rekriteFaz 1
- University of Kansas Cancer Center, Fairway · 3 mi lwen
Etid Sendwòm myelodisplastik nan lòt vil
- Houston, TX43 etid
- Baldwin Park, CA26 etid
- New York City, NY21 etid
- Seattle, WA21 etid
- Washington, DC20 etid
- Tampa, FL19 etid
- Boston, MA19 etid
- Miami, FL17 etid
- Columbus, OH14 etid
- Durham, NC14 etid
- St. Louis, MO13 etid
- Atlanta, GA13 etid
Lòt etid nan Overland Park
- Kansè Poumon ki pa ti selil16 etid
- Leksemi mieloïd egi11 etid
- Kansè poumon11 etid
- Kansè nan tete10 etid
- Fibrilasyon atriyal8 etid
- Kansè kolorektal8 etid
- Obèsite7 etid
- Kansè pankreyas7 etid
- Kansè pwostat7 etid
- Melanom6 etid
- Sipwa6 etid
- Kansè ovè6 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.